Calcium Load in the Aortic Valve, Aortic Root, and Left Ventricular Outflow Tract and the Risk for a Periprocedural Stroke.

Cerebral protection device Outcome TAVR Transcatheter aortic valve replacement

Journal

Structural heart : the journal of the Heart Team
ISSN: 2474-8714
Titre abrégé: Struct Heart
Pays: United States
ID NLM: 101743256

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 04 03 2022
revised: 07 06 2022
accepted: 17 06 2022
medline: 8 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: epublish

Résumé

Periprocedural stroke during transcatheter aortic valve implantation is a rare but devastating complication. The calcified aortic valve is the most likely source of the emboli in a periprocedural stroke. The total load and distribution of calcium in the leaflets, aortic root, and left ventricular outflow tract varies from patient to patient. Consequently, there could be patterns of calcification that are associated with a higher risk of stroke. This study aimed to explore whether the pattern of calcification in the left ventricular outflow tract, annulus, aortic valve, and ascending aorta can be used to predict a periprocedural stroke. Among the 3282 consecutive patients who received a transcatheter aortic valve implantation in the native valve in Sweden from 2014 to 2018, we identified 52 who had a periprocedural stroke. From the same cohort, a control group of 52 patients was constructed by propensity score matching. Both groups had one missing cardiac computed tomography, and 51 stroke and 51 control patients were blindly reviewed by an experienced radiologist. The groups were well balanced in terms of demographics and procedural data. Of the 39 metrics created to describe calcium pattern, only one differed between the groups. The length of calcium protruding above the annulus was 10.6 mm (interquartile range 7-13.6) for patients without stroke and 8 mm (interquartile range 3-10) for stroke patients. This study could not find any pattern of calcification that predisposes for a periprocedural stroke.

Sections du résumé

Background UNASSIGNED
Periprocedural stroke during transcatheter aortic valve implantation is a rare but devastating complication. The calcified aortic valve is the most likely source of the emboli in a periprocedural stroke. The total load and distribution of calcium in the leaflets, aortic root, and left ventricular outflow tract varies from patient to patient. Consequently, there could be patterns of calcification that are associated with a higher risk of stroke. This study aimed to explore whether the pattern of calcification in the left ventricular outflow tract, annulus, aortic valve, and ascending aorta can be used to predict a periprocedural stroke.
Methods UNASSIGNED
Among the 3282 consecutive patients who received a transcatheter aortic valve implantation in the native valve in Sweden from 2014 to 2018, we identified 52 who had a periprocedural stroke. From the same cohort, a control group of 52 patients was constructed by propensity score matching. Both groups had one missing cardiac computed tomography, and 51 stroke and 51 control patients were blindly reviewed by an experienced radiologist.
Results UNASSIGNED
The groups were well balanced in terms of demographics and procedural data. Of the 39 metrics created to describe calcium pattern, only one differed between the groups. The length of calcium protruding above the annulus was 10.6 mm (interquartile range 7-13.6) for patients without stroke and 8 mm (interquartile range 3-10) for stroke patients.
Conclusions UNASSIGNED
This study could not find any pattern of calcification that predisposes for a periprocedural stroke.

Identifiants

pubmed: 37288334
doi: 10.1016/j.shj.2022.100070
pii: S2474-8706(22)01860-7
pmc: PMC10242559
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100070

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

H. Bjursten has served as a consultant for Boston Scientific and Edwards Lifesciences. N. Samano received honorarium from Edwards Lifesciences. A. Rück has served as a consultant and received research support from 10.13039/100008497Boston Scientific and 10.13039/100006520Edwards Lifesciences. S. James received proctoring fees from Medtronic. M. Settergren has served as a consultant and advisory boards for Boston Scientific, Edwards Lifesciences, Abbott Vascular, and WL Gore. M. Götberg has ​served as a consultant for Boston Scientific. The other authors had no conflicts to declare.

Références

J Interv Cardiol. 2018 Oct;31(5):648-654
pubmed: 29900591
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
J Cardiovasc Comput Tomogr. 2018 Jul - Aug;12(4):338-343
pubmed: 29735255
J Am Coll Cardiol. 2017 Jan 31;69(4):367-377
pubmed: 27815101
JACC Cardiovasc Interv. 2021 Mar 8;14(5):515-527
pubmed: 33663779
Catheter Cardiovasc Interv. 2017 Feb 15;89(3):470-477
pubmed: 27121306
Eur Heart J. 2018 Nov 7;39(42):3777-3779
pubmed: 30239697
J Cardiovasc Comput Tomogr. 2017 Jul - Aug;11(4):302-308
pubmed: 28457950
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2297-2303
pubmed: 28917515
J Am Coll Cardiol. 2015 Jul 21;66(3):209-217
pubmed: 26184612
Circ Cardiovasc Interv. 2016 Sep;9(9):
pubmed: 27601429
J Interv Cardiol. 2018 Dec;31(6):891-898
pubmed: 30467892
Circ Cardiovasc Interv. 2019 Mar;12(3):e007546
pubmed: 30871358
Interv Cardiol. 2017 Sep;12(2):128-132
pubmed: 29588741
Cardiovasc Revasc Med. 2020 Jun;21(6):717-722
pubmed: 31175048
Eur Heart J. 2019 Oct 14;40(39):3263-3269
pubmed: 31433472
J Am Coll Cardiol. 2015 Jul 14;66(2):113-21
pubmed: 26055947
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
Eur Heart J. 2019 May 1;40(17):1334-1340
pubmed: 30590554
J Cardiovasc Comput Tomogr. 2020 Jul - Aug;14(4):307-313
pubmed: 31874792
Int J Cardiovasc Imaging. 2019 Nov;35(11):2123-2133
pubmed: 31312998
Circulation. 2012 Dec 18;126(25):3041-53
pubmed: 23149669
J Thorac Dis. 2018 Mar;10(3):1927-1935
pubmed: 29707348
J Thorac Cardiovasc Surg. 2015 Mar;149(3):799-805.e1-2
pubmed: 25455466

Auteurs

Henrik Bjursten (H)

Department of Cardiothoracic Surgery, Skåne University Hospital, Lund University, Lund, Sweden.

Sasha Koul (S)

Department of Clinical Sciences Lund, Cardiology, Skåne University Hospital, Lund University, Lund, Sweden.

Olov Duvernoy (O)

Section of Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Erika Fagman (E)

Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Sahlgrenska Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Ninos Samano (N)

Faculty of Medicine and Health, University Health Care Research Centre, Örebro University, Örebro, Sweden.

Johan Nilsson (J)

Institution of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Niels Erik Nielsen (NE)

Department of Cardiology, Heart Centre, University Hospital, Linköping, Sweden.

Andreas Rück (A)

Department of Cardiology, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden.

Jan Johansson (J)

Department of Cardiology, Blekinge Hospital, Karlskrona, Sweden.

Stefan James (S)

Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.

Magnus Settergren (M)

Department of Cardiology, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden.

Matthias Götberg (M)

Department of Clinical Sciences Lund, Cardiology, Skåne University Hospital, Lund University, Lund, Sweden.

Adrian Pistea (A)

Department of Radiology, Skåne University Hospital, Lund University, Lund, Sweden.

Classifications MeSH